131 results
6-K
EX-99.4
AMYT
Amryt Pharma Plc
12 Apr 23
Current report (foreign)
5:28pm
Pharma’s team has delivered innovative treatments to rare disease patients with high unmet medical needs. By joining forces and expertise we will be able … Global Rare Diseases
Chiesi Global Rare Diseases is a business unit of the Chiesi Group established to deliver innovative therapies and solutions
6-K
EX-99.1
AMYT
Amryt Pharma Plc
3 Apr 23
High Court of Justice of England and Wales Sanctions Scheme of Arrangement
9:00am
2023.
About Amryt
Amryt is a global commercial-stage biopharmaceutical company focused on acquiring, developing and commercializing innovative
6-K
EX-99.6
AMYT
Amryt Pharma Plc
3 Nov 22
Current report (foreign)
7:44am
, our mission is to transform the lives of people affected by rare, debilitating conditions by providing innovative medicines that bring hope to those … -stage biopharmaceutical company focused on acquiring, developing and commercializing innovative treatments to help improve the lives of patients
6-K
EX-99.3
AMYT
Amryt Pharma Plc
3 Nov 22
Current report (foreign)
7:44am
#.
About AmrytAmryt is a global commercial-stage biopharmaceutical company focused on acquiring, developing and commercializing innovative treatments
6-K
EX-99.1
AMYT
Amryt Pharma Plc
3 Nov 22
Current report (foreign)
7:44am
.
About AmrytAmryt is a global commercial-stage biopharmaceutical company focused on acquiring, developing and commercializing innovative treatments
6-K
EX-99.2
3wg0h6q
3 Nov 22
Current report (foreign)
7:44am
6-K
EX-99.4
rnt2cq
3 Nov 22
Current report (foreign)
7:44am
6-K
EX-99.5
5bli9g
3 Nov 22
Current report (foreign)
7:44am
6-K
EX-99.7
nt60w3mbd i8i45shy
3 Nov 22
Current report (foreign)
7:44am
6-K
EX-99.1
eoxj139u k23vu
4 Aug 22
Results of Annual General Meeting
7:38am
6-K
EX-99.2
2449rvepsrxe o19
4 Aug 22
Results of Annual General Meeting
7:38am
6-K
EX-99.3
ad9sz
4 Aug 22
Results of Annual General Meeting
7:38am
6-K
EX-99.5
lwa875a2azoek5 cl9
4 Aug 22
Results of Annual General Meeting
7:38am
6-K
EX-99.4
r0wtqk6
4 Aug 22
Results of Annual General Meeting
7:38am
6-K
EX-99.3
0xhvq odklc45wsea1
1 Jul 22
Posting of Annual Report and Notice of AGM
6:00am
6-K
EX-99.2
va2 cv228ajy9
1 Jul 22
Posting of Annual Report and Notice of AGM
6:00am
6-K
EX-99.1
yxcktr4gnn8z1ycsx63
1 Jul 22
Posting of Annual Report and Notice of AGM
6:00am
6-K
EX-99.4
cwodhoxj4
1 Jul 22
Posting of Annual Report and Notice of AGM
6:00am
6-K
EX-99.1
fqcsj
24 Jun 22
Filsuvez® recently approved by the European Commission for the treatment of EB
7:18am
6-K
EX-99.1
692wo8 pm
23 Jun 22
European Commission Approves Filsuvez® for the treatment of Dystrophic and Junctional EB
7:26am